We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KRUS:NASDAQKura Sushi USA, Inc. Analysis

Data as of 2026-08-13 - not real-time

$52.43

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Kura Sushi USA, Inc. is priced at $52.43 and its moving averages line up in bearish order, the shorter trailing the longer. It has lost 11.9% over the past 30 days. Relative strength is 60.7 — approaching overbought — and the MACD signal is bullish. The recent range runs from support at $43.21 up to resistance at $52.67.
Multiples put this in fair territory at a P/E of 224.4. The average analyst target implies 23.8% above today's level. Revenue is growing at 16.2% on a -0.7% profit margin.
Risk scores 8 out of 10, which is high for this asset class. With 30-day volatility of 48.5%, a beta of 0.95 and a maximum drawdown of 49.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
This one splits by horizon — sell in the near term, hold further out, at 3/10 long-term conviction.

Top Market Events

Kura Sushi USA Inc KRUS reports improved profit margins and strategic expansions despite facing traffic declines and...Sushi restaurant chain Kura Sushi NASDAQ:KRUS fell short of the market’s revenue expectations in Q2 CY2026, but sales...Kura Sushi turned a profit surprise in Q3, posting $0.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 57.16
  • MACD momentum is positive

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 57.16
  • Analyst targets imply +23.8% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 3/10

Key Factors

  • Negative profit margin of -0.7%
  • Analyst targets imply +23.8% versus the current price
  • Negative return on equity of -0.9%

Key Metrics & Analysis

Financial Health

Revenue Growth16.20%
Profit Margin-0.65%
P/E Ratio224.4
ROE-0.91%
ROA-0.40%
Debt/Equity90.08
P/B Ratio2.8
Op. Cash Flow$27.8M
Free Cash Flow$-32445124

Technical Analysis

TrendBearish
RSI60.7
Support$43.21
Resistance$52.67
MA 20$47.32
MA 50$49.47
MA 200$57.16
MACDBullish
VolumeDecreasing
Fear & Greed Index95.45

Valuation

Fair Value$26.49
Target Price$64.89
Upside/Downside23.76%
GradeFair
TypeGrowth

Risk Assessment

Beta0.95
Volatility48.47%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.